Get the Stockscreener App
1.61
3.21%
0.05
After Hours:
1.63
0.02
+1.24%
60 Degrees Pharmaceuticals Inc stock is traded at $1.61, with a volume of 85,534.
It is up +3.21% in the last 24 hours and up +15.00% over the past month.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
See More
Previous Close:
$1.56
Open:
$1.57
24h Volume:
85,534
Relative Volume:
0.16
Market Cap:
$6.61M
Revenue:
$502.40K
Net Income/Loss:
$-7.91M
P/E Ratio:
-0.1615
EPS:
-9.972
Net Cash Flow:
$-4.32M
1W Performance:
+8.78%
1M Performance:
+15.00%
6M Performance:
-45.61%
1Y Performance:
-68.43%
1-Day Range:
$1.55
$1.63
1-Week Range:
$1.42
$1.71
52-Week Range:
$1.215
$12.45
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Name
60 Degrees Pharmaceuticals Inc
Sector
Industry
Phone
202-327-5422
Address
1025 CONNECTICUT AVENUE NW, WASHINGTON
Compare SXTP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SXTP
60 Degrees Pharmaceuticals Inc
|
1.61 | 6.40M | 502.40K | -7.91M | -4.32M | -9.972 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
60 Degrees Pharmaceuticals Inc Stock (SXTP) Latest News
Using data models to predict 60 Degrees Pharmaceuticals Inc. stock movement2025 Dividend Review & Fast Entry Momentum Alerts - newser.com
Measuring 60 Degrees Pharmaceuticals Inc.’s beta against major indicesEntry Point & AI Powered Buy/Sell Recommendations - newser.com
Live market analysis of 60 Degrees Pharmaceuticals Inc.Bond Market & Fast Gain Swing Trade Alerts - newser.com
What machine learning models say about 60 Degrees Pharmaceuticals Inc.Market Growth Review & Capital Protection Trading Alerts - newser.com
Is 60 Degrees Pharmaceuticals Inc. stock oversold or undervaluedMarket Growth Review & Fast Exit and Entry Trade Guides - newser.com
Predicting 60 Degrees Pharmaceuticals Inc. Equity Warrant trend using moving averagesWeekly Trend Recap & Verified Short-Term Plans - newser.com
Live market analysis of 60 Degrees Pharmaceuticals Inc. Equity Warrant2025 Investor Takeaways & Expert Approved Momentum Ideas - newser.com
60 Degrees Pharmaceuticals Inc. stock chart pattern explainedPortfolio Value Summary & Accurate Trade Setup Notifications - newser.com
What high frequency data says about 60 Degrees Pharmaceuticals Inc.Quarterly Risk Review & Weekly Top Gainers Alerts - newser.com
Detecting support and resistance levels for 60 Degrees Pharmaceuticals Inc. Equity WarrantQuarterly Profit Report & Weekly Watchlist for Consistent Profits - newser.com
Will 60 Degrees Pharmaceuticals Inc. Equity Warrant outperform the marketJuly 2025 Analyst Calls & Weekly High Momentum Picks - newser.com
Top chart patterns to watch in 60 Degrees Pharmaceuticals Inc.Quarterly Growth Report & Daily Momentum Trading Reports - newser.com
Will 60 Degrees Pharmaceuticals Inc. stock attract more institutional investorsTake Profit & Weekly Watchlist of Top Performers - newser.com
Join 60 Degrees Pharmaceuticals' Exclusive Live Investor Webinar and Q&A Session on October 22 - The Daily Jeffersonian
Is it time to cut losses on 60 Degrees Pharmaceuticals Inc.2025 Dividend Review & Community Driven Trade Alerts - newser.com
Enlivex Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Canton Repository
60 Degrees Pharmaceuticals stockholders approve board, equity plan amendment and reverse split - Investing.com
60 Degrees Pharmaceuticals Holds Annual Stockholders Meeting - TipRanks
Visual trend scoring systems applied to 60 Degrees Pharmaceuticals Inc.2025 Dividend Review & Short-Term High Return Ideas - newser.com
Can 60 Degrees Pharmaceuticals Inc. stock sustain market leadershipStop Loss & Free AI Powered Buy and Sell Recommendations - newser.com
How buybacks impact 60 Degrees Pharmaceuticals Inc. stock valueJuly 2025 Weekly Recap & Trade Opportunity Analysis - newser.com
Is Rajeswari Infrastructure Limiteds Business Model Sustainable Long TermResistance Breakout Alerts & Affordable Investment Tips - earlytimes.in
60 Degrees Pharma names first chronic babesiosis trial B-FREE By Investing.com - Investing.com Canada
60 Degrees Pharma names first chronic babesiosis trial B-FREE - Investing.com India
60 Degrees Pharmaceuticals Launches B-FREE Chronic Babesiosis Study Following Patient Naming Competition and $5K Charity Donation - Quiver Quantitative
60 Degrees Pharmaceuticals Unveils Name of Chronic Babesiosis Clinical Trial: B-FREE Chronic Babesiosis Study - GlobeNewswire
12-Month Phase 2 Study: 60 Degrees Pharma's B-FREE Trial of ARAKODA® for Chronic Babesiosis - Stock Titan
Is 60 Degrees Pharmaceuticals Inc. stock reversal real or fakeJuly 2025 News Drivers & Low Drawdown Momentum Trade Ideas - newser.com
Why retail investors pile into 60 Degrees Pharmaceuticals Inc. stock2025 Winners & Losers & Real-Time Buy Signal Alerts - newser.com
Can machine learning forecast 60 Degrees Pharmaceuticals Inc. Equity Warrant recoveryJuly 2025 Selloffs & AI Enhanced Trading Alerts - newser.com
Is 60 Degrees Pharmaceuticals Inc Equity Warrant a good long term investmentStraddle and Strangle Trades & High Yield Market Growth - earlytimes.in
60 Degrees Pharmaceuticals Inc Stock (SXTP) Financials Data
Revenue
Net Income
Cash Flow
EPS
60 Degrees Pharmaceuticals Inc Stock (SXTP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| XU CHERYL | Director |
Dec 13 '24 |
Buy |
1.56 |
6,000 |
9,375 |
52,078 |
| XU CHERYL | Director |
Dec 12 '24 |
Buy |
1.82 |
5,000 |
9,125 |
46,078 |
| XU CHERYL | Director |
Dec 16 '24 |
Buy |
1.45 |
2,000 |
2,900 |
54,078 |
| DOW GEOFFREY S | President and CEO |
Dec 09 '24 |
Buy |
1.27 |
35,823 |
45,563 |
94,580 |
| DOW GEOFFREY S | President and CEO |
Dec 06 '24 |
Buy |
1.20 |
20,579 |
24,672 |
58,757 |
| DOW GEOFFREY S | President and CEO |
Dec 05 '24 |
Buy |
1.11 |
17,549 |
19,520 |
38,178 |
| DOW GEOFFREY S | President and CEO |
Nov 21 '24 |
Buy |
0.91 |
3,500 |
3,195 |
20,629 |
| DOW GEOFFREY S | President and CEO |
Nov 19 '24 |
Buy |
0.90 |
2,500 |
2,248 |
16,129 |
| DOW GEOFFREY S | President and CEO |
Nov 20 '24 |
Buy |
0.92 |
1,000 |
924 |
17,129 |
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):